The initiation and progression of atherosclerotic cardiovascular disease (ASCVD) has always been associated with a series of risk factors. Evidences of statin therapy from randomized clinical trials are abundant, whereas discussions regarding patients with ASCVD without evidence-based risk factors are rare. Here, we describe a case of a 58-year-old woman who was diagnosed with ASCVD with none of these evidence-based risk factors. After four years of medical interventions, including atorvastatin, the patient recovered completely from severe chest pain with significant regression of atherosclerotic plaques in coronary arteries.
CITATION STYLE
Guan, S., Zhang, Y., Wang, B., & Li, W. (2019). Medical therapy induced regression of plaque in a female patient with ASCVD. International Heart Journal, 60(1), 175–177. https://doi.org/10.1536/ihj.17-394
Mendeley helps you to discover research relevant for your work.